Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 16061480)

1.

Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.

Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH, Wu CT, Chang C.

J Biol Chem. 2005 Sep 30;280(39):33558-65. Epub 2005 Aug 1.

2.

Mechanisms of prostate cancer cell survival after inhibition of AR expression.

Cohen MB, Rokhlin OW.

J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022. Review.

PMID:
19115258
3.

Interleukin-6 regulation of prostate cancer cell growth.

Culig Z, Steiner H, Bartsch G, Hobisch A.

J Cell Biochem. 2005 Jun 1;95(3):497-505. Review.

PMID:
15838876
4.

Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype?

Finnberg N, El-Deiry WS.

Cancer Biol Ther. 2004 Jul;3(7):614-6. Epub 2004 Jul 24. Review.

5.

The androgen receptor mRNA.

Yeap BB, Wilce JA, Leedman PJ.

Bioessays. 2004 Jun;26(6):672-82. Review.

PMID:
15170865
6.

[Involvement of PI3K/Akt pathway in prostate cancer. Potential strategies for developing targeted therapies].

Pommery N, Hénichart JP.

Ann Pharm Fr. 2005 Jan;63(1):69-75. Review. French.

PMID:
15803103
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk